BENZOYL PEROXIDE 8% / NIACINAMIDE 4%- benzoyl peroxide 8% / niacinamide 4% suspension 
Sincerus Florida

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BENZOYL PEROXIDE 8% / NIACINAMIDE 4%

Directions for use

d

Sincerus Florida, LLC. Adverse reactions

ds

Active, inactive

d

NDC 72934-8022-6 BENZOYL PEROXIDE USP 8% / NIACINAMIDE USP 4%. Suspension 120gm.

s

BENZOYL PEROXIDE 8% / NIACINAMIDE 4% 
benzoyl peroxide 8% / niacinamide 4% suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-8022
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOYL PEROXIDE (UNII: W9WZN9A0GM) (BENZOYL PEROXIDE - UNII:W9WZN9A0GM) BENZOYL PEROXIDE8 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-8022-6120 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product05/11/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/11/2019
Labeler - Sincerus Florida (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-8022)

Revised: 5/2019
Document Id: 888b2203-46a4-d599-e053-2995a90a7de1
Set id: 888b2203-46a3-d599-e053-2995a90a7de1
Version: 1
Effective Time: 20190510
 
Sincerus Florida